Ballast Point and River Cities back TissueTech

Regenerative tissue engineering company TissueTech has closed $15 million in funding. The investors were River Cities Capital Funds and Ballast Point Ventures.

ByIris Dorbian

23 June 2015•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

North America US Briefs

Ballast Point and River Cities back TissueTech

Ballast Point Ventures

RC Capital